AMIDOYL
Dead / Abandoned — Abandoned — after ex parte appeal (as of 19 Oct 2017)
What this means for you
This application is over — abandoned 19 Oct 2017. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86925130
- Mark type
- Stylized text
- Filed
- 01 Mar 2016
- Abandoned
- 19 Oct 2017
- Attorney of record
- James David Johnson
Goods and services
- Class 005 — Pharmaceuticals: Dietary and nutritional supplements; dietary food supplements; dietary supplements; dietary supplements for therapeutic purposes; dietary supplements containing fatty acid amides to enhance the biological response and entourage effect of endocannabinoids, cannabinoids, and alkylamides
Owner
- Boston Research & Development, LLC, Norwood, MA, US
Prosecution history
- 19 Oct 2017 — ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL
- 19 Oct 2017 — ABANDONMENT - AFTER EX PARTE APPEAL
- 19 Oct 2017 — EXPARTE APPEAL TERMINATED
- 09 Sept 2017 — EXPARTE APPEAL DISMISSED - FAILURE TO FILE BRIEF
- 30 Jun 2017 — EX PARTE APPEAL-INSTITUTED
- 30 Jun 2017 — EXPARTE APPEAL RECEIVED AT TTAB
- 09 Jan 2017 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 09 Jan 2017 — FINAL REFUSAL E-MAILED
- 09 Jan 2017 — FINAL REFUSAL WRITTEN
- 15 Dec 2016 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 14 Dec 2016 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 14 Dec 2016 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 14 Jun 2016 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 Jun 2016 — NON-FINAL ACTION E-MAILED
- 14 Jun 2016 — NON-FINAL ACTION WRITTEN